These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6941787

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Anticentromere antibody, CREST and cancer].
    Boyeldieu D, Rouquette-Gally AM, Laugier A, Abuaf N.
    Presse Med; 1987 Nov 14; 16(38):1924-5. PubMed ID: 2962150
    [No Abstract] [Full Text] [Related]

  • 4. [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].
    Rouquette-Gally AM, Stern MH, Prost AC, Abuaf N, Homberg JC, Combrisson A.
    Presse Med; 1987 Nov 14; 14(28):1497-500. PubMed ID: 2931679
    [Abstract] [Full Text] [Related]

  • 5. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
    Fritzler MJ, Kinsella TD.
    Am J Med; 1980 Oct 14; 69(4):520-6. PubMed ID: 6968511
    [Abstract] [Full Text] [Related]

  • 6. Histocompatibility antigens in progressive systemic sclerosis (scleroderma).
    Birnbaum NS, Rodnan GP, Rabin BS, Bassion S.
    J Rheumatol; 1977 Oct 14; 4(4):425-8. PubMed ID: 604479
    [Abstract] [Full Text] [Related]

  • 7. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
    Tuffanelli DL, McKeon F, Kleinsmith DM, Burnham TK, Kirschner M.
    Arch Dermatol; 1983 Jul 14; 119(7):560-6. PubMed ID: 6859899
    [Abstract] [Full Text] [Related]

  • 8. [Two patients of CREST-primary biliary cirrhosis overlap syndrome with common HLA types].
    Kojima T, Ohira Y, Ishibashi K, Kuroda M, Takagi T, Saito K, Nishimaki T, Kasukawa R, Morito T, Oonami K.
    Nihon Shokakibyo Gakkai Zasshi; 1991 Jul 14; 88(7):1479-84. PubMed ID: 1920906
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants.
    McCarty GA, Rice JR, Bembe ML, Barada FA.
    Arthritis Rheum; 1983 Jan 14; 26(1):1-7. PubMed ID: 6337593
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
    Whiteside TL, Medsger TA, Rodnan GP.
    J Rheumatol; 1983 Feb 14; 10(1):128-31. PubMed ID: 6601709
    [Abstract] [Full Text] [Related]

  • 14. HLA antigens and scleroderma.
    Ercilla MG, Arriaga F, Gratacós MR, Coll J, Lecha V, Vives J, Castillo R.
    Arch Dermatol Res; 1981 Feb 14; 271(4):381-5. PubMed ID: 6949497
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.
    Chorzelski TP, Jablonska S, Beutner EH, Blaszczyk M, Jarzabek-Chorzelska M, Kencka D, Krasny S, Kumar V, Tchórzewska A.
    Br J Dermatol; 1985 Oct 14; 113(4):381-9. PubMed ID: 3877519
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of methods for detection of anticentromere antibodies and other antinuclear antibodies.
    Beutner EH, Krasny SA, Chorzelski TP, Rodnan G, Jablonska S, Kumar V.
    J Am Acad Dermatol; 1985 Feb 14; 12(2 Pt 1):289-95. PubMed ID: 3882784
    [Abstract] [Full Text] [Related]

  • 19. [Abnormal HLA-DR antigen expression in monocytes of patients with systemic lupus erythematosus and psoriasis vulgaris].
    Volk HD, Diezel W, Waschke SR, Barthelmes H, Grunow R, Fiebig H, Sönnichsen N.
    Dermatol Monatsschr; 1985 Feb 14; 171(5):308-11. PubMed ID: 3926547
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.